Intentions for bilateral mastectomy among newly diagnosed breast cancer patients

Journal of Surgical Oncology

Volumn 107, Issue 7, 2013, Pages 772-776

  King, Lesley ^a   O'Neill, Suzanne C ^a   Spellman, Elizabeth ^a   Peshkin, Beth N ^a   Valdimarsdottir, Heiddis ^b   Willey, Shawna ^a   Leventhal, Kara Grace ^a   Demarco, Tiffani ^a   Nusbaum, Rachel ^a   Feldman, Elizabeth ^a   Jandorf, Lina ^b   Schwartz, Marc D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; decisions; intentions; young women

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER PATIENT; CANCER RISK; CONFLICT; DECISION MAKING; DISTRESS SYNDROME; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NEUROSIS; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; ANXIETY DISORDERS; BREAST NEOPLASMS; CONFLICT (PSYCHOLOGY); DECISION MAKING; EDUCATIONAL STATUS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; INTENTION; LINEAR MODELS; MARITAL STATUS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; UNITED STATES;

EID: 84878313866     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23307     Document Type: Article

References (37)

1. Arrington AK, Jarosek SL, Virnig BA, et al.: Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 2009; 16: 2697-2704.
2. Tuttle TM, Habermann EB, Grund EH, et al.: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 2007; 25: 5203-5209.
3. Yao K, Stewart AK, Winchester DJ, et al.: Trends in contralateral prophylactic mastectomy for unilateral cancer: A report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol 2010; 17: 2554-2562.
4. Schwartz MD, Lerman C, Brogan B, et al.: Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004; 22: 1823-1829.
5. Schrag D, Kuntz KM, Garber JE, et al.: Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 2000; 283: 617-624.
6. King TA, Sakr R, Patil S, et al.: Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 2011; 29: 2158-2164.
7. Chung A, Huynh K, Lawrence C, et al.: Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol 2012; 19: 2600-2606.
8. Fisher CS, Martin-Dunlap T, Ruppel MB, et al.: Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Ann Surg Oncol 2012; 19: 3246-3250.
9. Metcalfe KA, Lubinski J, Ghadirian P, et al.: Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 2008; 26: 1093-1097.
10. Ji J, Hemminki K:, Risk for contralateral breast cancers in a population covered by mammography: Effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 2007; 105: 229-236.
11. Rawal R, Lorenzo BJ, Hemminki K:, Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening. Br J Cancer 2005; 92: 162-166.
12. Bedrosian I, Hu CY, Chang GJ:, Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 2010; 102: 401-409.
13. Herrinton LJ, Barlow WE, Yu O, et al.: Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. J Clin Oncol 2005; 23: 4275-4286.
14. McDonnell SK, Schaid DJ, Myers JL, et al.: Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 2001; 19: 3938-3943.
15. Frost MH, Slezak JM, Tran NV, et al.: Satisfaction after contralateral prophylactic mastectomy: The significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 2005; 23: 7849-7856.
16. Geiger AM, West CN, Nekhlyudov L, et al.: Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 2006; 24: 1350-1356.
17. Graves KD, Vegella P, Poggi EA, et al.: Long-term psychosocial outcomes of BRCA1/BRCA2 testing: Differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev 2012; 21: 445-455.
18. Tercyak KP, Peshkin BN, Brogan BM, et al.: Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 2007; 25: 285-291.
19. Beesley H, Ullmer H, Holcombe C, et al.: How patients evaluate breast reconstruction after mastectomy, and why their evaluation often differs from that of their clinicians. J Plast Reconstr Aesthet Surg 2012; 65: 1064-1071.
20. Abbott A, Rueth N, Pappas-Varco S, et al.: Perceptions of contralateral breast cancer: An overestimation of risk. Ann Surg Oncol 2011; 18: 3129-3136.
21. Hawley ST, Griggs JJ, Hamilton AS, et al.: Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 2009; 101: 1337-1347.
22. Collins ED, Moore CP, Clay KF, et al.: Can women with early-stage breast cancer make an informed decision for mastectomy ? J Clin Oncol 2009; 27: 519-525.
23. Lee CN, Chang Y, Adimorah N, et al.: Decision making about surgery for early-stage breast cancer. J Am Coll Surg 2012; 214: 1-10.
24. Caldon LJ, Collins KA, Wilde DJ, et al.: Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer. Br J Cancer 2011; 104: 1551-1557.
25. Johnson JD, Roberts CS, Cox CE, et al.: Breast cancer patients' personality style, age, and treatment decision making. J Surg Oncol 1996; 63: 183-186.
26. Katz SJ, Hawley ST, Abrahamse P, et al.: Does it matter where you go for breast surgery?: Attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care 2010; 48: 892-899.
27. Morrow M, Jagsi R, Alderman AK, et al.: Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009; 302: 1551-1556.
28. University of Texas Southwestern Medical Center at Dallas, The BayesMendel Group at Johns Hopkins. CancerGene. Version 5.1. Available: http://www4.utsouthwestern.edu/breasthealth/cagene/ Accessed October 16, 2012.
29. Schwartz MD, Isaacs C, Graves KD, et al.: Long-term outcomes of BRCA1/BRCA2 testing: Risk reduction and surveillance. Cancer 2012; 118: 510-517.
30. Horowitz M, Wilner N, Alvarez W:, Impact of event scale: A measure of subjective stress. Psychosom Med 1979; 41: 209-218.
31. Derogatis LR, Melisaratos N:, The brief symptom inventory: An introductory report. Psychol Med 1983; 13: 595-605.
32. Costa PT, McCrae RR:, NEO-PI-R professional manual. Odessa, FL: Psychological Assessment Resources, Inc.; 1992.
33. O'Connor AM:, Validation of a decisional conflict scale. Med Decis Making 1995; 15: 25-30.
34. Bleicher RJ, Abrahamse P, Hawley ST, et al.: The influence of age on the breast surgery decision-making process. Ann Surg Oncol 2008; 15: 854-862.
35. Blinman P, Alam M, Duric V, et al.: Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review. Lung Cancer 2010; 69: 141-147.
36. O'Neill SC, Valdimarsdottir HB, DeMarco TA, et al.: BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat 2010; 124: 755-764.
37. Ozanne EM, Wittenberg E, Garber JE, et al.: Breast cancer prevention: Patient decision making and risk communication in the high risk setting. Breast J 2010; 16: 38-47.